Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 60

1.

Synoptic Versus Narrative Reporting of Prostate Biopsies at a Tertiary Healthcare Institution: Challenges, successes and expectations.

Orah NO, Anunobi CC, Ojewola RW.

Sultan Qaboos Univ Med J. 2017 Aug;17(3):e319-e323. doi: 10.18295/squmj.2017.17.03.010. Epub 2017 Oct 10.

3.

Lectins: an effective tool for screening of potential cancer biomarkers.

Hashim OH, Jayapalan JJ, Lee CS.

PeerJ. 2017 Sep 7;5:e3784. doi: 10.7717/peerj.3784. eCollection 2017.

4.

Detection rate of prostate cancer following biopsy among the northern Han Chinese population: a single-center retrospective study of 1022 cases.

Jia Y, Zhu LY, Xian YX, Sun XQ, Gao JG, Zhang XH, Hou SC, Zhang CC, Liu ZX.

World J Surg Oncol. 2017 Aug 29;15(1):165. doi: 10.1186/s12957-017-1238-9.

5.

Surface-enhanced Raman spectroscopy of serum accurately detects prostate cancer in patients with prostate-specific antigen levels of 4-10 ng/mL.

Chen N, Rong M, Shao X, Zhang H, Liu S, Dong B, Xue W, Wang T, Li T, Pan J.

Int J Nanomedicine. 2017 Jul 27;12:5399-5407. doi: 10.2147/IJN.S137756. eCollection 2017.

6.

A Panel of MicroRNAs as Diagnostic Biomarkers for the Identification of Prostate Cancer.

Daniel R, Wu Q, Williams V, Clark G, Guruli G, Zehner Z.

Int J Mol Sci. 2017 Jun 16;18(6). pii: E1281. doi: 10.3390/ijms18061281.

7.

Transperineal template-guided saturation biopsy aimed at sampling one core for each milliliter of prostate volume: 103 cases requiring repeat prostate biopsy.

Nakai Y, Tanaka N, Anai S, Miyake M, Hori S, Tatsumi Y, Morizawa Y, Fujii T, Konishi N, Fujimoto K.

BMC Urol. 2017 Apr 5;17(1):28. doi: 10.1186/s12894-017-0219-1.

8.

Urinary Biomarker Panel to Improve Accuracy in Predicting Prostate Biopsy Result in Chinese Men with PSA 4-10‚ÄČng/mL.

Zhou Y, Li Y, Li X, Jiang M.

Biomed Res Int. 2017;2017:2512536. doi: 10.1155/2017/2512536. Epub 2017 Feb 15.

9.

Long Non-Coding RNA as Potential Biomarker for Prostate Cancer: Is It Making a Difference?

Deng J, Tang J, Wang G, Zhu YS.

Int J Environ Res Public Health. 2017 Mar 7;14(3). pii: E270. doi: 10.3390/ijerph14030270. Review.

10.

Molecular and Functional Diagnostic Tools in Precision Oncology for Urological Malignancies.

Sekar V, Mehrotra DG, Majumder B.

Indian J Surg Oncol. 2017 Mar;8(1):24-32. doi: 10.1007/s13193-016-0591-4. Epub 2016 Dec 15. Review.

PMID:
28127179
11.

The increased expression of fatty acid-binding protein 9 in prostate cancer and its prognostic significance.

Al Fayi MS, Gou X, Forootan SS, Al-Jameel W, Bao Z, Rudland PR, Cornford PA, Hussain SA, Ke Y.

Oncotarget. 2016 Dec 13;7(50):82783-82797. doi: 10.18632/oncotarget.12635.

12.

Minimally invasive prostate cancer detection test using FISH probes.

Tinawi-Aljundi R, Knuth ST, Gildea M, Khal J, Hafron J, Kernen K, Di Loreto R, Aurich-Costa J.

Res Rep Urol. 2016 Jul 27;8:105-11. doi: 10.2147/RRU.S109450. eCollection 2016.

13.

Risk stratification of prostate cancer: integrating multiparametric MRI, nomograms and biomarkers.

Watson MJ, George AK, Maruf M, Frye TP, Muthigi A, Kongnyuy M, Valayil SG, Pinto PA.

Future Oncol. 2016 Nov;12(21):2417-2430. Epub 2016 Jul 12. Review.

14.

Evolving lessons on nanomaterial-coated viral vectors for local and systemic gene therapy.

Kasala D, Yoon AR, Hong J, Kim SW, Yun CO.

Nanomedicine (Lond). 2016 Jul;11(13):1689-713. doi: 10.2217/nnm-2016-0060. Epub 2016 Jun 27.

15.

Evaluation and characterization of anti-RalA autoantibody as a potential serum biomarker in human prostate cancer.

Li J, Dai L, Lei N, Xing M, Li P, Luo C, Casiano CA, Zhang JY.

Oncotarget. 2016 Jul 12;7(28):43546-43556. doi: 10.18632/oncotarget.9869.

16.

miR-301a expression: A prognostic marker for prostate cancer.

Damodaran C, Das TP, Papu John AM, Suman S, Kolluru V, Morris TJ, Faber EN, Rai SN, Messer JC, Alatassi H, Ankem MK.

Urol Oncol. 2016 Aug;34(8):336.e13-20. doi: 10.1016/j.urolonc.2016.03.009. Epub 2016 Apr 26.

17.

An Estimate of the Incidence of Prostate Cancer in Africa: A Systematic Review and Meta-Analysis.

Adeloye D, David RA, Aderemi AV, Iseolorunkanmi A, Oyedokun A, Iweala EE, Omoregbe N, Ayo CK.

PLoS One. 2016 Apr 13;11(4):e0153496. doi: 10.1371/journal.pone.0153496. eCollection 2016. Review.

18.

Prostasomes as a source of diagnostic biomarkers for prostate cancer.

Zijlstra C, Stoorvogel W.

J Clin Invest. 2016 Apr 1;126(4):1144-51. doi: 10.1172/JCI81128. Epub 2016 Apr 1. Review.

19.

Age-specific Serum Prostate Specific Antigen Ranges Among Apparently Healthy Nigerian Men Without Clinical Evidence of Prostate Cancer.

Ikuerowo SO, Ajala MO, Abolarinwa AA, Omisanjo OA.

Niger J Surg. 2016 Jan-Jun;22(1):5-8. doi: 10.4103/1117-6806.169821.

20.

Experimental and theoretical investigation of the precise transduction mechanism in giant magnetoresistive biosensors.

Lee JR, Sato N, Bechstein DJ, Osterfeld SJ, Wang J, Gani AW, Hall DA, Wang SX.

Sci Rep. 2016 Jan 5;6:18692. doi: 10.1038/srep18692.

Supplemental Content

Support Center